LifeMap Solutions claims that Asthma Health app users as engaged (or more) with Asthma Health as they are with games and social networks.
The Bluetooth-enabled, smartphone-connected device measures critical lung function with comparable accuracy to clinical-grade spirometers.
FDA-approved marketing claims of improved adherence and reduction in exacerbations address key unmet needs in respiratory health.
With Adherium's smartphone-connected device, the medication adherence increases by up to 59% in adults and 180% in children with asthma.
Said app enables asthma patients to participate in a study by using their iPhones; the new features enable participants to use the app with their physicians.
Also the three studies Adherium has conducted have found a 14.9% increase in lung function and a 37% reduction in oral steroid usage.
Called My Asthma Pal, the application runs of iOS and Android devices, providing children and their parents with a mobile tool to track and manage asthma.
Featuring medical-grade accuracy, the device has been launched on crowdfunding website Indiegogo, with the goal of raising $50,000 in a month-long campaign.
The device will monitor air quality, CO2 levels in the blood, physical activity, breathing, emotional states and other stimuli to identify asthma triggers.
GSK will use the sensor in the studies to automatically collect and record data on the inhaler's usage, and wirelessly transmit the data collected.